Male breast cancer diagnosis leads to new treatment tool

In 2018, Christopher Gregg, Ph.D., a member of the Nuclear Control of Cell Growth and Differentiation Program at Huntsman Cancer Institute at the University of Utah (the U) and neuroscientist and professor of Neurobiology and Human Genetics, faced a life-altering diagnosis—stage 4 metastatic breast cancer.

What followed was not just a personal battle but the catalyst for an innovative approach that could redefine cancer treatment.

Gregg’s diagnosis drove him to contemplate better ways to tackle his treatment journey. He soon recognized a fundamental issue in metastatic cancer: its…